Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1993-4-15
|
pubmed:abstractText |
Parathyroid hormone-related protein (PTHrP) was measured in plasma by a new immunoradiometric assay (IRMA) from Nichols Institute. The assay is specific for PTHrP and shows excellent parallelism when measuring keratinocyte fluid, samples with high PTHrP content, and PTHrP-supplemented plasma. A precision profile established the assay detection limit at 0.7 pmol/L. PTHrP was unstable in plasma, but the degradation rate was patient-specific. Because delay in separation resulted in loss of PTHrP immunoreactivity, samples were collected into tubes containing protease inhibitors (aprotinin, leupeptin, pepstatin, and EDTA) and separated within 30 min. Among normal subjects, 78% had PTHrP values greater than the detection limit; the reference range established was < 0.7-2.6 pmol/L. Of patients with hypercalcemia associated with malignancy, 46% had PTHrP > 2.6 pmol/L. PTHrP was increased in patients with breast (73%), genitourinary (64%), or lung (46%) malignancy but was rarely above normal in patients with hematological (29%) or gastrointestinal (33%) malignancy. PTHrP and nephrogenous cyclic adenosine monophosphate (NcAMP) were strongly correlated (r = 0.63, P < 0.01) in 37 patients with PTHrP values greater than the detection limit, but 8 patients had PTHrP and parathyroid hormone [PTH(1-84)] values below the limit of detection with inappropriate or increased NcAMP. Five of these eight patients had small cell carcinoma of lung. These patients may have secreted a factor that is not detected by the IRMAs of PTHrP or PTH used in this study but that produces hypercalcemia by means of cAMP-mediated mechanisms.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0009-9147
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
39
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
414-9
|
pubmed:dateRevised |
2006-6-29
|
pubmed:meshHeading |
pubmed-meshheading:8448850-Adult,
pubmed-meshheading:8448850-Aged,
pubmed-meshheading:8448850-Aged, 80 and over,
pubmed-meshheading:8448850-Humans,
pubmed-meshheading:8448850-Hyperparathyroidism,
pubmed-meshheading:8448850-Immunoradiometric Assay,
pubmed-meshheading:8448850-Middle Aged,
pubmed-meshheading:8448850-Neoplasms,
pubmed-meshheading:8448850-Parathyroid Hormone-Related Protein,
pubmed-meshheading:8448850-Proteins
|
pubmed:year |
1993
|
pubmed:articleTitle |
Clinical and laboratory studies of a new immunoradiometric assay of parathyroid hormone-related protein.
|
pubmed:affiliation |
University Department of Clinical Chemistry, Royal Liverpool University Hospital, UK.
|
pubmed:publicationType |
Journal Article
|